Trial intelligence / Profile preview

Corticosteroid vs Dextrose vs Ozone for Carpal Tunnel Syndrome

NCT07002892Recruiting

Start
Jan 2025
Primary completion
Jan 2026
Modality
Inhalation Devices
Countries
1
01

Overview

Randomised, triple-blind trial of medical ozonated water and dextrose in carpal tunnel syndrome (CTS) (3 arms). Primary endpoint: Visual Analog Scale at 24 weeks. Started Jan 2025; status: recruiting.

02

Drugs

medical ozonated waterdextrose
03

Conditions

carpal tunnel syndrome (CTS)

Beyond the preview

Go deeper on NCT07002892.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07002892.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call